

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 8.57718979 |
| 2 | rhodopsin mediated signaling pathway (GO:0016056) | 8.44520959 |
| 3 | retinal cone cell development (GO:0046549) | 6.79015111 |
| 4 | photoreceptor cell maintenance (GO:0045494) | 6.22115891 |
| 5 | photoreceptor cell development (GO:0042461) | 6.07492697 |
| 6 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.06115018 |
| 7 | detection of light stimulus involved in visual perception (GO:0050908) | 5.89875416 |
| 8 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.89875416 |
| 9 | eye photoreceptor cell development (GO:0042462) | 5.74447303 |
| 10 | regulation of actin filament-based movement (GO:1903115) | 5.53578201 |
| 11 | retinal rod cell development (GO:0046548) | 5.23131960 |
| 12 | GMP metabolic process (GO:0046037) | 5.00626082 |
| 13 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.91285117 |
| 14 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.85746385 |
| 15 | regulation of guanylate cyclase activity (GO:0031282) | 4.65130033 |
| 16 | phototransduction (GO:0007602) | 4.61246624 |
| 17 | actin filament-based movement (GO:0030048) | 4.60395081 |
| 18 | detection of light stimulus (GO:0009583) | 4.58691560 |
| 19 | detection of visible light (GO:0009584) | 4.49499814 |
| 20 | phototransduction, visible light (GO:0007603) | 4.48785238 |
| 21 | regulation of cell communication by electrical coupling (GO:0010649) | 4.45113676 |
| 22 | regulation of the force of heart contraction (GO:0002026) | 4.35135976 |
| 23 | striated muscle hypertrophy (GO:0014897) | 4.34893975 |
| 24 | visual perception (GO:0007601) | 4.29952683 |
| 25 | response to pheromone (GO:0019236) | 4.28659402 |
| 26 | sensory perception of light stimulus (GO:0050953) | 4.28569442 |
| 27 | protein-chromophore linkage (GO:0018298) | 4.27265879 |
| 28 | eye photoreceptor cell differentiation (GO:0001754) | 4.27004221 |
| 29 | photoreceptor cell differentiation (GO:0046530) | 4.27004221 |
| 30 | actomyosin structure organization (GO:0031032) | 4.26837006 |
| 31 | skeletal muscle contraction (GO:0003009) | 4.21181786 |
| 32 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.20624972 |
| 33 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.07880988 |
| 34 | protein K11-linked deubiquitination (GO:0035871) | 3.99587320 |
| 35 | response to inactivity (GO:0014854) | 3.98628904 |
| 36 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.91970782 |
| 37 | retina development in camera-type eye (GO:0060041) | 3.88046070 |
| 38 | cellular response to light stimulus (GO:0071482) | 3.83718668 |
| 39 | muscle tissue morphogenesis (GO:0060415) | 3.77466618 |
| 40 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.77119896 |
| 41 | cardiac myofibril assembly (GO:0055003) | 3.74997719 |
| 42 | muscle hypertrophy (GO:0014896) | 3.74012617 |
| 43 | regulation of striated muscle contraction (GO:0006942) | 3.72743515 |
| 44 | muscle contraction (GO:0006936) | 3.68573521 |
| 45 | response to muscle activity (GO:0014850) | 3.56302813 |
| 46 | regulation of sarcomere organization (GO:0060297) | 3.54880020 |
| 47 | detection of external stimulus (GO:0009581) | 3.51248234 |
| 48 | detection of abiotic stimulus (GO:0009582) | 3.46734865 |
| 49 | regulation of cGMP metabolic process (GO:0030823) | 3.46297104 |
| 50 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.44303815 |
| 51 | muscle hypertrophy in response to stress (GO:0003299) | 3.44303815 |
| 52 | cardiac muscle adaptation (GO:0014887) | 3.44303815 |
| 53 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.44033355 |
| 54 | relaxation of cardiac muscle (GO:0055119) | 3.42534902 |
| 55 | muscle system process (GO:0003012) | 3.41000612 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.40132908 |
| 57 | striated muscle adaptation (GO:0014888) | 3.37341905 |
| 58 | piRNA metabolic process (GO:0034587) | 3.35765032 |
| 59 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.35467152 |
| 60 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.34293330 |
| 61 | synaptic vesicle endocytosis (GO:0048488) | 3.32305648 |
| 62 | skeletal muscle fiber development (GO:0048741) | 3.29728691 |
| 63 | negative regulation of protein localization to cell surface (GO:2000009) | 3.25964578 |
| 64 | myotube cell development (GO:0014904) | 3.19506059 |
| 65 | plasma membrane repair (GO:0001778) | 3.18904283 |
| 66 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.18843308 |
| 67 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.18797598 |
| 68 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.18320964 |
| 69 | muscle cell fate commitment (GO:0042693) | 3.16891247 |
| 70 | nonmotile primary cilium assembly (GO:0035058) | 3.16801155 |
| 71 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.14909073 |
| 72 | muscle fiber development (GO:0048747) | 3.14592003 |
| 73 | myofibril assembly (GO:0030239) | 3.14075357 |
| 74 | cardiac muscle cell development (GO:0055013) | 3.12827182 |
| 75 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.11996233 |
| 76 | regulation of cGMP biosynthetic process (GO:0030826) | 3.11946421 |
| 77 | regulation of membrane repolarization (GO:0060306) | 3.11618666 |
| 78 | cell communication by electrical coupling (GO:0010644) | 3.11591127 |
| 79 | peripheral nervous system axon ensheathment (GO:0032292) | 3.10803124 |
| 80 | myelination in peripheral nervous system (GO:0022011) | 3.10803124 |
| 81 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.07794594 |
| 82 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.07452697 |
| 83 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.05520203 |
| 84 | skeletal muscle adaptation (GO:0043501) | 3.04132758 |
| 85 | sodium ion export (GO:0071436) | 3.01943689 |
| 86 | cardiac cell development (GO:0055006) | 3.00833965 |
| 87 | potassium ion export (GO:0071435) | 3.00784622 |
| 88 | striated muscle cell development (GO:0055002) | 2.99282693 |
| 89 | cardiac muscle contraction (GO:0060048) | 2.99054354 |
| 90 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.95983926 |
| 91 | relaxation of muscle (GO:0090075) | 2.95807015 |
| 92 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.92853777 |
| 93 | regulation of cardioblast differentiation (GO:0051890) | 2.91581128 |
| 94 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.88483548 |
| 95 | regulation of heart rate (GO:0002027) | 2.87348785 |
| 96 | regulation of cardiac muscle contraction (GO:0055117) | 2.87039905 |
| 97 | neuromuscular synaptic transmission (GO:0007274) | 2.86330487 |
| 98 | lymphangiogenesis (GO:0001946) | 2.84007349 |
| 99 | sarcomere organization (GO:0045214) | 2.83462957 |
| 100 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.82825846 |
| 101 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.82825846 |
| 102 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.81592822 |
| 103 | positive regulation of cation channel activity (GO:2001259) | 2.81170115 |
| 104 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.81043889 |
| 105 | response to epinephrine (GO:0071871) | 2.80413711 |
| 106 | positive regulation of cGMP metabolic process (GO:0030825) | 2.79246513 |
| 107 | muscle filament sliding (GO:0030049) | 2.79182750 |
| 108 | actin-myosin filament sliding (GO:0033275) | 2.79182750 |
| 109 | regulation of sequestering of triglyceride (GO:0010889) | 2.78499560 |
| 110 | cellular response to epinephrine stimulus (GO:0071872) | 2.77833762 |
| 111 | mitotic metaphase plate congression (GO:0007080) | 2.76388669 |
| 112 | regulation of heart contraction (GO:0008016) | 2.76319827 |
| 113 | skeletal muscle tissue development (GO:0007519) | 2.74930598 |
| 114 | endocardial cushion development (GO:0003197) | 2.73139544 |
| 115 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.71889562 |
| 116 | cardiac chamber formation (GO:0003207) | 2.71521219 |
| 117 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.71415784 |
| 118 | regulation of muscle contraction (GO:0006937) | 2.71305131 |
| 119 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.70454589 |
| 120 | muscle organ development (GO:0007517) | 2.70330991 |
| 121 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.69812467 |
| 122 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.69702745 |
| 123 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.69308117 |
| 124 | striated muscle atrophy (GO:0014891) | 2.69277337 |
| 125 | muscle structure development (GO:0061061) | 2.69079645 |
| 126 | regulation of muscle system process (GO:0090257) | 2.67660537 |
| 127 | male meiosis (GO:0007140) | 2.67056224 |
| 128 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.65684553 |
| 129 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.63210407 |
| 130 | negative regulation of hormone metabolic process (GO:0032351) | 2.63210407 |
| 131 | cardiac muscle cell action potential (GO:0086001) | 2.60813647 |
| 132 | behavioral response to ethanol (GO:0048149) | 2.60141512 |
| 133 | glycogen catabolic process (GO:0005980) | 2.59548618 |
| 134 | regulation of ATPase activity (GO:0043462) | 2.59326274 |
| 135 | regulation of ATP catabolic process (GO:1903289) | 2.59326274 |
| 136 | actin-mediated cell contraction (GO:0070252) | 2.58838286 |
| 137 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.56570129 |
| 138 | coronary vasculature morphogenesis (GO:0060977) | 2.56249177 |
| 139 | regulation of skeletal muscle contraction (GO:0014819) | 2.55241820 |
| 140 | muscle adaptation (GO:0043500) | 2.55094206 |
| 141 | muscle cell development (GO:0055001) | 2.55025388 |
| 142 | adult heart development (GO:0007512) | 2.54664111 |
| 143 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.54216439 |
| 144 | axoneme assembly (GO:0035082) | 2.53379063 |
| 145 | membrane depolarization during action potential (GO:0086010) | 2.52993148 |
| 146 | atrial cardiac muscle cell action potential (GO:0086014) | 2.52980971 |
| 147 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.52394708 |
| 148 | cellular potassium ion homeostasis (GO:0030007) | 2.51829724 |
| 149 | striated muscle contraction (GO:0006941) | 2.46344436 |
| 150 | lactate metabolic process (GO:0006089) | 2.45736217 |
| 151 | positive regulation of mRNA 3-end processing (GO:0031442) | 2.44509580 |
| 152 | ventricular cardiac muscle cell development (GO:0055015) | 2.44302232 |
| 153 | protein polyglutamylation (GO:0018095) | 2.43640820 |
| 154 | microtubule depolymerization (GO:0007019) | 2.43527120 |
| 155 | cellular sodium ion homeostasis (GO:0006883) | 2.43274310 |
| 156 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.43245917 |
| 157 | positive regulation of synapse maturation (GO:0090129) | 2.42720677 |
| 158 | potassium ion homeostasis (GO:0055075) | 2.42231182 |
| 159 | regulation of relaxation of muscle (GO:1901077) | 2.40549471 |
| 160 | glycolytic process (GO:0006096) | 2.40278879 |
| 161 | calcium ion import (GO:0070509) | 2.39686202 |
| 162 | cellular response to radiation (GO:0071478) | 2.39053133 |
| 163 | cell communication involved in cardiac conduction (GO:0086065) | 2.39033806 |
| 164 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.38814030 |
| 165 | cardiac muscle hypertrophy (GO:0003300) | 2.38011599 |
| 166 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.34407072 |
| 167 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.33251428 |
| 168 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.32676935 |
| 169 | sperm motility (GO:0030317) | 2.31880574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.20938554 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.80168505 |
| 3 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.46757918 |
| 4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.29541518 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.21499468 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.08889692 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.06995851 |
| 8 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.06303060 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.04053298 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.91902051 |
| 11 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.89606651 |
| 12 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.88443983 |
| 13 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82934916 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82013217 |
| 15 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.80844478 |
| 16 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80568313 |
| 17 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.78952827 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 1.76748103 |
| 19 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.75668327 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.74600766 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.74354703 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73182894 |
| 23 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.59536791 |
| 24 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.58919700 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.58859219 |
| 26 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.58110435 |
| 27 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54211403 |
| 28 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.53130678 |
| 29 | TP53_16413492_ChIP-PET_HCT116_Human | 1.52144343 |
| 30 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45881220 |
| 31 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.45832173 |
| 32 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.43884223 |
| 33 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43194074 |
| 34 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.42302250 |
| 35 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.42210714 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40842442 |
| 37 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.40715787 |
| 38 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40529921 |
| 39 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40013913 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39278893 |
| 41 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.38575049 |
| 42 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.38575049 |
| 43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.36114978 |
| 44 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.34345083 |
| 45 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34345083 |
| 46 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.33130462 |
| 47 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30925207 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.30562134 |
| 49 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.29698252 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28939913 |
| 51 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28627407 |
| 52 | CJUN_26792858_Chip-Seq_BT549_Human | 1.28053880 |
| 53 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26495745 |
| 54 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.25256436 |
| 55 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24854454 |
| 56 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.23921197 |
| 57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.23881855 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.21456804 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21322321 |
| 60 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.20726151 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20463085 |
| 62 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.19826128 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.19731678 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19059135 |
| 65 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18220148 |
| 66 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17627897 |
| 67 | AR_19668381_ChIP-Seq_PC3_Human | 1.17546051 |
| 68 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17514512 |
| 69 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.17510542 |
| 70 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.17437203 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16794176 |
| 72 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.15122262 |
| 73 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14861915 |
| 74 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.14450280 |
| 75 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.14098540 |
| 76 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.14098540 |
| 77 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.13440854 |
| 78 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13242156 |
| 79 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12858605 |
| 80 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12581851 |
| 81 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.12432920 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11357515 |
| 83 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.11342615 |
| 84 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11317290 |
| 85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11052925 |
| 86 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10710051 |
| 87 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.10598808 |
| 88 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09988881 |
| 89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08162652 |
| 90 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.07907756 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.07517678 |
| 92 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.05869651 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03361408 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02990217 |
| 95 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02480533 |
| 96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01926901 |
| 97 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01257012 |
| 98 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.00486217 |
| 99 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.00223389 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99652907 |
| 101 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98750718 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98684001 |
| 103 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.98518079 |
| 104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98355831 |
| 105 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98154575 |
| 106 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98051449 |
| 107 | * GF1_26923725_Chip-Seq_HPCs_Mouse | 0.97844431 |
| 108 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97665848 |
| 109 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.97578160 |
| 110 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97555397 |
| 111 | * GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97451693 |
| 112 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.97211284 |
| 113 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.97032741 |
| 114 | NFYA_21822215_ChIP-Seq_K562_Human | 0.96886306 |
| 115 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96840942 |
| 116 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.96752199 |
| 117 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96733906 |
| 118 | * RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.96520761 |
| 119 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95828041 |
| 120 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95670453 |
| 121 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.95410064 |
| 122 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95080157 |
| 123 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.95067287 |
| 124 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94670906 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94571856 |
| 126 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.94432609 |
| 127 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.94411344 |
| 128 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.93644379 |
| 129 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.90485958 |
| 130 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90030693 |
| 131 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89913666 |
| 132 | NFYB_21822215_ChIP-Seq_K562_Human | 0.89213669 |
| 133 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.88722730 |
| 134 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88408116 |
| 135 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.88069967 |
| 136 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88050049 |
| 137 | * ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.87574982 |
| 138 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87459339 |
| 139 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87368016 |
| 140 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87276621 |
| 141 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86398198 |
| 142 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.86213035 |
| 143 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.86031573 |
| 144 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.85663356 |
| 145 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.84918433 |
| 146 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.84778458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 5.86457936 |
| 2 | MP0003011_delayed_dark_adaptation | 4.59323968 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 4.25334014 |
| 4 | MP0005253_abnormal_eye_physiology | 3.98695667 |
| 5 | MP0003646_muscle_fatigue | 3.08889743 |
| 6 | MP0002638_abnormal_pupillary_reflex | 2.85431459 |
| 7 | MP0003950_abnormal_plasma_membrane | 2.83943610 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.74387673 |
| 9 | MP0004130_abnormal_muscle_cell | 2.68515317 |
| 10 | MP0004215_abnormal_myocardial_fiber | 2.56382506 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.40457694 |
| 12 | MP0005195_abnormal_posterior_eye | 2.37828390 |
| 13 | MP0000747_muscle_weakness | 2.32048662 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.09615960 |
| 15 | MP0004510_myositis | 2.05953413 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.05630815 |
| 17 | MP0002653_abnormal_ependyma_morphology | 1.97672061 |
| 18 | MP0005391_vision/eye_phenotype | 1.91857500 |
| 19 | MP0000733_abnormal_muscle_development | 1.84909887 |
| 20 | MP0001324_abnormal_eye_pigmentation | 1.84151902 |
| 21 | MP0002837_dystrophic_cardiac_calcinosis | 1.82893780 |
| 22 | MP0001984_abnormal_olfaction | 1.76998150 |
| 23 | MP0002127_abnormal_cardiovascular_syste | 1.71502183 |
| 24 | MP0000751_myopathy | 1.69469439 |
| 25 | MP0006292_abnormal_olfactory_placode | 1.67887864 |
| 26 | MP0000749_muscle_degeneration | 1.67484496 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.60703079 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.58068010 |
| 29 | MP0004233_abnormal_muscle_weight | 1.57849616 |
| 30 | MP0002752_abnormal_somatic_nervous | 1.54122630 |
| 31 | MP0002229_neurodegeneration | 1.54060115 |
| 32 | MP0003718_maternal_effect | 1.53626671 |
| 33 | MP0003137_abnormal_impulse_conducting | 1.51330666 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.47253206 |
| 35 | MP0005620_abnormal_muscle_contractility | 1.42576681 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.40296741 |
| 37 | MP0002108_abnormal_muscle_morphology | 1.40031583 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.35894932 |
| 39 | MP0001502_abnormal_circadian_rhythm | 1.34505313 |
| 40 | MP0002090_abnormal_vision | 1.34287339 |
| 41 | MP0005451_abnormal_body_composition | 1.34202088 |
| 42 | MP0008775_abnormal_heart_ventricle | 1.32934501 |
| 43 | MP0002972_abnormal_cardiac_muscle | 1.31628031 |
| 44 | MP0005410_abnormal_fertilization | 1.31272190 |
| 45 | MP0004085_abnormal_heartbeat | 1.27390823 |
| 46 | MP0002102_abnormal_ear_morphology | 1.24190626 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.20442687 |
| 48 | MP0001299_abnormal_eye_distance/ | 1.19801980 |
| 49 | MP0005330_cardiomyopathy | 1.19571692 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.16828906 |
| 51 | MP0003111_abnormal_nucleus_morphology | 1.16114515 |
| 52 | MP0002269_muscular_atrophy | 1.15220875 |
| 53 | MP0004147_increased_porphyrin_level | 1.15172841 |
| 54 | MP0003698_abnormal_male_reproductive | 1.14592354 |
| 55 | MP0001929_abnormal_gametogenesis | 1.12971012 |
| 56 | MP0002106_abnormal_muscle_physiology | 1.12809470 |
| 57 | MP0004087_abnormal_muscle_fiber | 1.12450863 |
| 58 | MP0008569_lethality_at_weaning | 1.11424305 |
| 59 | MP0001486_abnormal_startle_reflex | 1.10096510 |
| 60 | MP0009384_cardiac_valve_regurgitation | 1.10053326 |
| 61 | MP0005377_hearing/vestibular/ear_phenot | 1.09746717 |
| 62 | MP0003878_abnormal_ear_physiology | 1.09746717 |
| 63 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09714649 |
| 64 | MP0004885_abnormal_endolymph | 1.09266284 |
| 65 | MP0008260_abnormal_autophagy | 1.09034322 |
| 66 | MP0004859_abnormal_synaptic_plasticity | 1.08524859 |
| 67 | MP0009250_abnormal_appendicular_skeleto | 1.04908743 |
| 68 | MP0003121_genomic_imprinting | 1.02412278 |
| 69 | MP0003879_abnormal_hair_cell | 1.02125884 |
| 70 | MP0001485_abnormal_pinna_reflex | 1.01768751 |
| 71 | MP0003123_paternal_imprinting | 1.01103736 |
| 72 | MP0002272_abnormal_nervous_system | 1.00191950 |
| 73 | MP0010368_abnormal_lymphatic_system | 0.99826959 |
| 74 | MP0005248_abnormal_Harderian_gland | 0.99255878 |
| 75 | MP0003693_abnormal_embryo_hatching | 0.98985344 |
| 76 | MP0005187_abnormal_penis_morphology | 0.96826557 |
| 77 | MP0002734_abnormal_mechanical_nocicepti | 0.94955620 |
| 78 | MP0000566_synostosis | 0.93943830 |
| 79 | MP0009745_abnormal_behavioral_response | 0.93334561 |
| 80 | MP0001764_abnormal_homeostasis | 0.93037149 |
| 81 | MP0008789_abnormal_olfactory_epithelium | 0.92207911 |
| 82 | MP0002184_abnormal_innervation | 0.91972646 |
| 83 | MP0005670_abnormal_white_adipose | 0.91327996 |
| 84 | MP0002067_abnormal_sensory_capabilities | 0.91027332 |
| 85 | MP0004142_abnormal_muscle_tone | 0.90809767 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.90310239 |
| 87 | MP0006138_congestive_heart_failure | 0.90274721 |
| 88 | MP0002210_abnormal_sex_determination | 0.90116209 |
| 89 | MP0005369_muscle_phenotype | 0.90110868 |
| 90 | MP0001968_abnormal_touch/_nociception | 0.89945016 |
| 91 | MP0002971_abnormal_brown_adipose | 0.89912798 |
| 92 | MP0000534_abnormal_ureter_morphology | 0.89891016 |
| 93 | MP0003045_fibrosis | 0.89711188 |
| 94 | MP0003635_abnormal_synaptic_transmissio | 0.89559600 |
| 95 | MP0002234_abnormal_pharynx_morphology | 0.88359902 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.88325955 |
| 97 | MP0002064_seizures | 0.88299660 |
| 98 | MP0009046_muscle_twitch | 0.86718297 |
| 99 | MP0005394_taste/olfaction_phenotype | 0.84490520 |
| 100 | MP0005499_abnormal_olfactory_system | 0.84490520 |
| 101 | MP0001440_abnormal_grooming_behavior | 0.84442348 |
| 102 | MP0002161_abnormal_fertility/fecundity | 0.83473457 |
| 103 | MP0003279_aneurysm | 0.83116483 |
| 104 | MP0001970_abnormal_pain_threshold | 0.80565957 |
| 105 | MP0010630_abnormal_cardiac_muscle | 0.78860725 |
| 106 | MP0005646_abnormal_pituitary_gland | 0.78212149 |
| 107 | MP0002733_abnormal_thermal_nociception | 0.77758056 |
| 108 | MP0003828_pulmonary_edema | 0.77756334 |
| 109 | MP0000653_abnormal_sex_gland | 0.77623957 |
| 110 | MP0004484_altered_response_of | 0.77254899 |
| 111 | MP0000631_abnormal_neuroendocrine_gland | 0.77127813 |
| 112 | MP0000750_abnormal_muscle_regeneration | 0.77107801 |
| 113 | MP0006276_abnormal_autonomic_nervous | 0.75745002 |
| 114 | MP0001963_abnormal_hearing_physiology | 0.75493395 |
| 115 | MP0003699_abnormal_female_reproductive | 0.74903406 |
| 116 | MP0000266_abnormal_heart_morphology | 0.74133565 |
| 117 | MP0008058_abnormal_DNA_repair | 0.73259089 |
| 118 | MP0001544_abnormal_cardiovascular_syste | 0.73043318 |
| 119 | MP0005385_cardiovascular_system_phenoty | 0.73043318 |
| 120 | MP0008007_abnormal_cellular_replicative | 0.72923097 |
| 121 | MP0004134_abnormal_chest_morphology | 0.72373656 |
| 122 | MP0000013_abnormal_adipose_tissue | 0.71514245 |
| 123 | MP0001905_abnormal_dopamine_level | 0.70586268 |
| 124 | MP0000026_abnormal_inner_ear | 0.70515062 |
| 125 | MP0000778_abnormal_nervous_system | 0.69824444 |
| 126 | MP0002128_abnormal_blood_circulation | 0.69000176 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.68461584 |
| 128 | MP0002736_abnormal_nociception_after | 0.68215096 |
| 129 | MP0004270_analgesia | 0.67686714 |
| 130 | MP0000759_abnormal_skeletal_muscle | 0.67481895 |
| 131 | MP0003315_abnormal_perineum_morphology | 0.67034573 |
| 132 | MP0002063_abnormal_learning/memory/cond | 0.66439575 |
| 133 | MP0003567_abnormal_fetal_cardiomyocyte | 0.65735102 |
| 134 | MP0003787_abnormal_imprinting | 0.65642568 |
| 135 | MP0002572_abnormal_emotion/affect_behav | 0.63807458 |
| 136 | MP0005266_abnormal_metabolism | 0.63104392 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.62179542 |
| 138 | MP0003959_abnormal_lean_body | 0.59177558 |
| 139 | MP0001346_abnormal_lacrimal_gland | 0.59131353 |
| 140 | MP0006036_abnormal_mitochondrial_physio | 0.57672624 |
| 141 | MP0004272_abnormal_basement_membrane | 0.57539516 |
| 142 | MP0005595_abnormal_vascular_smooth | 0.56623462 |
| 143 | MP0004924_abnormal_behavior | 0.56092894 |
| 144 | MP0005386_behavior/neurological_phenoty | 0.56092894 |
| 145 | MP0000003_abnormal_adipose_tissue | 0.54162666 |
| 146 | MP0005375_adipose_tissue_phenotype | 0.53628506 |
| 147 | MP0005503_abnormal_tendon_morphology | 0.52626133 |
| 148 | MP0002876_abnormal_thyroid_physiology | 0.51133876 |
| 149 | MP0000767_abnormal_smooth_muscle | 0.51090111 |
| 150 | MP0002066_abnormal_motor_capabilities/c | 0.49156386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bony spicule pigmentary retinopathy (HP:0007737) | 8.31638573 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 7.98586115 |
| 3 | Nemaline bodies (HP:0003798) | 7.92452457 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.85112299 |
| 5 | Abnormal rod and cone electroretinograms (HP:0008323) | 7.16146626 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 6.94540451 |
| 7 | Chorioretinal atrophy (HP:0000533) | 6.69869862 |
| 8 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 6.41980377 |
| 9 | Central scotoma (HP:0000603) | 6.17438990 |
| 10 | Pigmentary retinal degeneration (HP:0001146) | 6.16764899 |
| 11 | Pendular nystagmus (HP:0012043) | 5.97537274 |
| 12 | Abnormality of macular pigmentation (HP:0008002) | 5.71528101 |
| 13 | Attenuation of retinal blood vessels (HP:0007843) | 5.49793505 |
| 14 | Scotoma (HP:0000575) | 5.27383028 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 4.82400905 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.51258142 |
| 17 | Decreased central vision (HP:0007663) | 4.47352379 |
| 18 | Abolished electroretinogram (ERG) (HP:0000550) | 4.12667577 |
| 19 | Dyschromatopsia (HP:0007641) | 4.09831137 |
| 20 | Type II diabetes mellitus (HP:0005978) | 4.05171373 |
| 21 | Photophobia (HP:0000613) | 3.73975820 |
| 22 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.67847669 |
| 23 | Neck muscle weakness (HP:0000467) | 3.64375731 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 3.63126764 |
| 25 | Distal arthrogryposis (HP:0005684) | 3.60155417 |
| 26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.54355753 |
| 27 | Severe visual impairment (HP:0001141) | 3.48043699 |
| 28 | Myotonia (HP:0002486) | 3.43542631 |
| 29 | Myopathic facies (HP:0002058) | 3.30591204 |
| 30 | Retinitis pigmentosa (HP:0000510) | 3.27672457 |
| 31 | Increased variability in muscle fiber diameter (HP:0003557) | 3.26694109 |
| 32 | Rhabdomyolysis (HP:0003201) | 3.21758274 |
| 33 | Distal lower limb muscle weakness (HP:0009053) | 3.16162851 |
| 34 | Increased corneal curvature (HP:0100692) | 3.15309454 |
| 35 | Keratoconus (HP:0000563) | 3.15309454 |
| 36 | Choroideremia (HP:0001139) | 3.14701435 |
| 37 | Dilated cardiomyopathy (HP:0001644) | 3.13946652 |
| 38 | Difficulty running (HP:0009046) | 3.08993202 |
| 39 | Increased connective tissue (HP:0009025) | 3.08619897 |
| 40 | Round ear (HP:0100830) | 3.05768043 |
| 41 | Vitreoretinal degeneration (HP:0000655) | 3.05113632 |
| 42 | EMG: neuropathic changes (HP:0003445) | 2.99026485 |
| 43 | Absent phalangeal crease (HP:0006109) | 2.96942073 |
| 44 | Areflexia of lower limbs (HP:0002522) | 2.94192545 |
| 45 | Cone-rod dystrophy (HP:0000548) | 2.92818551 |
| 46 | Posterior subcapsular cataract (HP:0007787) | 2.91515206 |
| 47 | Exercise-induced myalgia (HP:0003738) | 2.78914690 |
| 48 | Macular degeneration (HP:0000608) | 2.76655125 |
| 49 | Constricted visual fields (HP:0001133) | 2.76222786 |
| 50 | Hip contracture (HP:0003273) | 2.75905745 |
| 51 | Slender build (HP:0001533) | 2.69168722 |
| 52 | Ulnar deviation of the wrist (HP:0003049) | 2.66087841 |
| 53 | Ventricular fibrillation (HP:0001663) | 2.57515088 |
| 54 | Frequent falls (HP:0002359) | 2.52133228 |
| 55 | Sudden death (HP:0001699) | 2.51079174 |
| 56 | Muscle stiffness (HP:0003552) | 2.48394932 |
| 57 | Atrial fibrillation (HP:0005110) | 2.48352575 |
| 58 | Gait imbalance (HP:0002141) | 2.46039910 |
| 59 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.45826099 |
| 60 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.45776964 |
| 61 | Calcaneovalgus deformity (HP:0001848) | 2.45716428 |
| 62 | Bundle branch block (HP:0011710) | 2.40335376 |
| 63 | Papillary thyroid carcinoma (HP:0002895) | 2.40060557 |
| 64 | Congenital primary aphakia (HP:0007707) | 2.38788166 |
| 65 | Pancreatic fibrosis (HP:0100732) | 2.38177690 |
| 66 | Left ventricular hypertrophy (HP:0001712) | 2.37116857 |
| 67 | Spinal rigidity (HP:0003306) | 2.36271965 |
| 68 | Exercise-induced muscle cramps (HP:0003710) | 2.35467045 |
| 69 | True hermaphroditism (HP:0010459) | 2.35347814 |
| 70 | Abnormal finger flexion creases (HP:0006143) | 2.35346803 |
| 71 | Syncope (HP:0001279) | 2.34208870 |
| 72 | Abnormality of the ischium (HP:0003174) | 2.34061687 |
| 73 | Generalized muscle weakness (HP:0003324) | 2.31401975 |
| 74 | Prolonged QT interval (HP:0001657) | 2.30281959 |
| 75 | Hyperkalemia (HP:0002153) | 2.28879280 |
| 76 | Hypoplastic ischia (HP:0003175) | 2.28290937 |
| 77 | Male infertility (HP:0003251) | 2.28064876 |
| 78 | Primary atrial arrhythmia (HP:0001692) | 2.27181079 |
| 79 | Medial flaring of the eyebrow (HP:0010747) | 2.21982204 |
| 80 | Nephrogenic diabetes insipidus (HP:0009806) | 2.20595764 |
| 81 | Deformed tarsal bones (HP:0008119) | 2.19420084 |
| 82 | Fetal akinesia sequence (HP:0001989) | 2.19274428 |
| 83 | Poor coordination (HP:0002370) | 2.17130762 |
| 84 | Limited hip movement (HP:0008800) | 2.17088745 |
| 85 | Muscular dystrophy (HP:0003560) | 2.16650198 |
| 86 | Supraventricular tachycardia (HP:0004755) | 2.13323808 |
| 87 | Distal lower limb amyotrophy (HP:0008944) | 2.10311506 |
| 88 | Scapular winging (HP:0003691) | 2.09863546 |
| 89 | Congenital sensorineural hearing impairment (HP:0008527) | 2.08184590 |
| 90 | Supraventricular arrhythmia (HP:0005115) | 2.04421397 |
| 91 | Hypoplasia of the fovea (HP:0007750) | 2.03680571 |
| 92 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.03680571 |
| 93 | Steppage gait (HP:0003376) | 2.02408262 |
| 94 | Calf muscle hypertrophy (HP:0008981) | 2.02009475 |
| 95 | Congenital stationary night blindness (HP:0007642) | 11.6456167 |
| 96 | Oligodactyly (hands) (HP:0001180) | 1.99778935 |
| 97 | Progressive cerebellar ataxia (HP:0002073) | 1.99418727 |
| 98 | Optic disc pallor (HP:0000543) | 1.97605900 |
| 99 | Bradycardia (HP:0001662) | 1.97280356 |
| 100 | Abnormality of the fovea (HP:0000493) | 1.97109025 |
| 101 | Weak cry (HP:0001612) | 1.94925941 |
| 102 | Malignant hyperthermia (HP:0002047) | 1.91391954 |
| 103 | Abnormality of the foot musculature (HP:0001436) | 1.91199890 |
| 104 | Abnormal EKG (HP:0003115) | 1.91089089 |
| 105 | Abnormality of the calf musculature (HP:0001430) | 1.89971494 |
| 106 | Gowers sign (HP:0003391) | 1.88956131 |
| 107 | Subcapsular cataract (HP:0000523) | 1.88692821 |
| 108 | Genital tract atresia (HP:0001827) | 1.87823530 |
| 109 | Wide nasal bridge (HP:0000431) | 1.87475549 |
| 110 | Abnormality of midbrain morphology (HP:0002418) | 1.86422867 |
| 111 | Molar tooth sign on MRI (HP:0002419) | 1.86422867 |
| 112 | Vaginal atresia (HP:0000148) | 1.86166879 |
| 113 | Hypoplastic heart (HP:0001961) | 1.85147883 |
| 114 | Lower limb amyotrophy (HP:0007210) | 1.83149987 |
| 115 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.80374862 |
| 116 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.79494792 |
| 117 | Myoglobinuria (HP:0002913) | 1.77955353 |
| 118 | Difficulty climbing stairs (HP:0003551) | 1.77766820 |
| 119 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.77186862 |
| 120 | Hypoplastic left heart (HP:0004383) | 1.76565486 |
| 121 | Oligodactyly (HP:0012165) | 1.75682180 |
| 122 | Ventricular tachycardia (HP:0004756) | 1.74152619 |
| 123 | Progressive visual loss (HP:0000529) | 1.71727282 |
| 124 | Foot dorsiflexor weakness (HP:0009027) | 1.70337124 |
| 125 | Febrile seizures (HP:0002373) | 1.70056955 |
| 126 | Bulbar palsy (HP:0001283) | 1.69553148 |
| 127 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.69396041 |
| 128 | Ventricular arrhythmia (HP:0004308) | 1.68199969 |
| 129 | Heart block (HP:0012722) | 1.67296289 |
| 130 | Pancreatic cysts (HP:0001737) | 1.66532565 |
| 131 | Limb-girdle muscle atrophy (HP:0003797) | 1.65519278 |
| 132 | Limb-girdle muscle weakness (HP:0003325) | 1.64471076 |
| 133 | Retinal atrophy (HP:0001105) | 1.63089092 |
| 134 | Genetic anticipation (HP:0003743) | 1.59845646 |
| 135 | Nephronophthisis (HP:0000090) | 1.59121827 |
| 136 | Waddling gait (HP:0002515) | 1.57286438 |
| 137 | Muscle fiber splitting (HP:0003555) | 1.57046952 |
| 138 | Dysdiadochokinesis (HP:0002075) | 1.56984207 |
| 139 | Atrioventricular block (HP:0001678) | 1.56185545 |
| 140 | Tinnitus (HP:0000360) | 1.55262409 |
| 141 | Lipoatrophy (HP:0100578) | 1.54064673 |
| 142 | Diaphragmatic weakness (HP:0009113) | 1.53867974 |
| 143 | Facial diplegia (HP:0001349) | 1.53324083 |
| 144 | Focal motor seizures (HP:0011153) | 1.52716630 |
| 145 | Hemiplegia (HP:0002301) | 1.51129630 |
| 146 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.49562194 |
| 147 | Subaortic stenosis (HP:0001682) | 1.49562194 |
| 148 | Anterior segment dysgenesis (HP:0007700) | 1.49367710 |
| 149 | Epileptic encephalopathy (HP:0200134) | 1.49199376 |
| 150 | Right ventricular cardiomyopathy (HP:0011663) | 1.48911124 |
| 151 | Septo-optic dysplasia (HP:0100842) | 1.47369626 |
| 152 | Abnormality of the lower motor neuron (HP:0002366) | 1.47059790 |
| 153 | Palpitations (HP:0001962) | 1.46955429 |
| 154 | Abnormality of the neuromuscular junction (HP:0003398) | 1.46829570 |
| 155 | Fatigable weakness (HP:0003473) | 1.46829570 |
| 156 | Severe Myopia (HP:0011003) | 1.46823084 |
| 157 | Congenital malformation of the right heart (HP:0011723) | 1.46108841 |
| 158 | Double outlet right ventricle (HP:0001719) | 1.46108841 |
| 159 | Proximal amyotrophy (HP:0007126) | 1.45948990 |
| 160 | Patellar aplasia (HP:0006443) | 1.45244241 |
| 161 | Dysmetric saccades (HP:0000641) | 1.44000872 |
| 162 | Abnormal atrioventricular conduction (HP:0005150) | 1.43275820 |
| 163 | Chorioretinal coloboma (HP:0000567) | 1.42699586 |
| 164 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.42262846 |
| 165 | Cystic liver disease (HP:0006706) | 1.39430685 |
| 166 | Protrusio acetabuli (HP:0003179) | 1.39243615 |
| 167 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.37654236 |
| 168 | Broad foot (HP:0001769) | 1.36924495 |
| 169 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.35861593 |
| 170 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.35019334 |
| 171 | Rimmed vacuoles (HP:0003805) | 1.33928715 |
| 172 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.33428635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.51690219 |
| 2 | STK38L | 3.92223983 |
| 3 | OBSCN | 3.62018017 |
| 4 | LATS1 | 3.49111908 |
| 5 | PRKD3 | 2.99874269 |
| 6 | FRK | 2.78611156 |
| 7 | GRK1 | 2.63169065 |
| 8 | PHKG1 | 2.51530924 |
| 9 | PHKG2 | 2.51530924 |
| 10 | PINK1 | 2.40776888 |
| 11 | LATS2 | 2.28541955 |
| 12 | STK38 | 2.23212430 |
| 13 | PBK | 2.04237127 |
| 14 | PLK4 | 2.02671209 |
| 15 | PDK4 | 1.98062860 |
| 16 | PDK3 | 1.98062860 |
| 17 | PIK3CG | 1.87230508 |
| 18 | STK24 | 1.86291645 |
| 19 | MAP3K4 | 1.79681137 |
| 20 | NEK1 | 1.73715066 |
| 21 | NEK2 | 1.68434267 |
| 22 | MAPK13 | 1.60474557 |
| 23 | TTK | 1.58676431 |
| 24 | NEK9 | 1.53702906 |
| 25 | PRKAA1 | 1.53642731 |
| 26 | MARK1 | 1.52509004 |
| 27 | MUSK | 1.48841968 |
| 28 | CDK3 | 1.45890587 |
| 29 | CASK | 1.45789881 |
| 30 | STK3 | 1.42660684 |
| 31 | MAPK12 | 1.41610935 |
| 32 | SRPK1 | 1.41125922 |
| 33 | IRAK2 | 1.40466183 |
| 34 | CCNB1 | 1.36212449 |
| 35 | TRPM7 | 1.33225254 |
| 36 | SGK2 | 1.32657624 |
| 37 | PAK6 | 1.32376729 |
| 38 | MAP3K6 | 1.27553596 |
| 39 | AKT3 | 1.26244539 |
| 40 | PLK3 | 1.25151202 |
| 41 | MOS | 1.24959771 |
| 42 | CHEK2 | 1.23921655 |
| 43 | MAP3K7 | 1.23887826 |
| 44 | INSRR | 1.22771800 |
| 45 | ROCK1 | 1.19306825 |
| 46 | PKN2 | 1.16664540 |
| 47 | LIMK1 | 1.15977501 |
| 48 | NTRK3 | 1.15181243 |
| 49 | TNIK | 1.14918784 |
| 50 | MAP2K7 | 1.12710410 |
| 51 | DYRK1A | 1.11933858 |
| 52 | DDR2 | 1.11865056 |
| 53 | LMTK2 | 1.09420446 |
| 54 | SGK494 | 1.07734043 |
| 55 | SGK223 | 1.07734043 |
| 56 | GRK7 | 1.07187992 |
| 57 | CAMK2G | 1.06365762 |
| 58 | PLK1 | 1.05988612 |
| 59 | PDK2 | 0.97000183 |
| 60 | WNK3 | 0.96870786 |
| 61 | NTRK2 | 0.95368938 |
| 62 | ZAK | 0.94035679 |
| 63 | PTK2B | 0.92872375 |
| 64 | MAPKAPK3 | 0.91413268 |
| 65 | ERBB4 | 0.89368098 |
| 66 | NUAK1 | 0.86247146 |
| 67 | PRKAA2 | 0.85601359 |
| 68 | SGK3 | 0.84263417 |
| 69 | BUB1 | 0.83143382 |
| 70 | ICK | 0.83136023 |
| 71 | PKN1 | 0.82684349 |
| 72 | BRAF | 0.82132872 |
| 73 | MKNK2 | 0.81712063 |
| 74 | WNK1 | 0.80552788 |
| 75 | CAMK4 | 0.79294030 |
| 76 | MAP2K1 | 0.77273948 |
| 77 | BRSK2 | 0.76235384 |
| 78 | ROCK2 | 0.76221819 |
| 79 | CAMK2B | 0.75222362 |
| 80 | MAPK11 | 0.73054479 |
| 81 | DMPK | 0.72841379 |
| 82 | BRSK1 | 0.67193028 |
| 83 | PRKD1 | 0.65827913 |
| 84 | ADRBK1 | 0.64440421 |
| 85 | PRKCG | 0.64331920 |
| 86 | MAP2K4 | 0.63588965 |
| 87 | UHMK1 | 0.61777927 |
| 88 | PDGFRA | 0.61297879 |
| 89 | PRKD2 | 0.61110304 |
| 90 | MYLK | 0.61071729 |
| 91 | CDC42BPA | 0.60066827 |
| 92 | TAOK1 | 0.59379631 |
| 93 | PRKCZ | 0.59190603 |
| 94 | TAOK3 | 0.59171146 |
| 95 | NTRK1 | 0.58949453 |
| 96 | CHEK1 | 0.58107674 |
| 97 | PNCK | 0.56869876 |
| 98 | ADRBK2 | 0.56026950 |
| 99 | MAPK7 | 0.55724505 |
| 100 | CAMK1G | 0.54137441 |
| 101 | PAK3 | 0.53890856 |
| 102 | CDK1 | 0.53686061 |
| 103 | CDK8 | 0.53435638 |
| 104 | DYRK2 | 0.52548491 |
| 105 | RPS6KA3 | 0.52313147 |
| 106 | MAPK4 | 0.50125362 |
| 107 | CAMK2A | 0.49208020 |
| 108 | PTK2 | 0.48206336 |
| 109 | MAP3K9 | 0.47715098 |
| 110 | KSR1 | 0.47452457 |
| 111 | GSK3B | 0.46663366 |
| 112 | CSNK1D | 0.45262763 |
| 113 | ATM | 0.45121437 |
| 114 | TIE1 | 0.44982089 |
| 115 | CAMK1D | 0.44686939 |
| 116 | CDC7 | 0.44134007 |
| 117 | RIPK1 | 0.43853312 |
| 118 | MARK3 | 0.43377192 |
| 119 | BLK | 0.42723248 |
| 120 | MINK1 | 0.42718318 |
| 121 | PRKACA | 0.42706434 |
| 122 | PRKCE | 0.42561242 |
| 123 | AURKB | 0.42083196 |
| 124 | DYRK1B | 0.42070454 |
| 125 | MTOR | 0.41449780 |
| 126 | PRKG1 | 0.41439407 |
| 127 | MAP3K5 | 0.40692861 |
| 128 | AURKA | 0.39709196 |
| 129 | PRKACB | 0.38946528 |
| 130 | CAMK2D | 0.38849824 |
| 131 | SGK1 | 0.38654418 |
| 132 | PLK2 | 0.38387433 |
| 133 | PRPF4B | 0.37795787 |
| 134 | MAPK10 | 0.37446843 |
| 135 | CDK2 | 0.37411305 |
| 136 | PRKACG | 0.37315517 |
| 137 | CDK5 | 0.35041504 |
| 138 | STK39 | 0.35014966 |
| 139 | BRD4 | 0.34677180 |
| 140 | EEF2K | 0.34293990 |
| 141 | AKT2 | 0.34213995 |
| 142 | RPS6KA2 | 0.33568208 |
| 143 | EPHA4 | 0.33377716 |
| 144 | PIK3CA | 0.33167946 |
| 145 | PDK1 | 0.32464977 |
| 146 | CSNK1E | 0.32110594 |
| 147 | CAMK1 | 0.30472874 |
| 148 | KSR2 | 0.30258725 |
| 149 | MET | 0.29184667 |
| 150 | RPS6KA6 | 0.25561206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.35328268 |
| 2 | Circadian rhythm_Homo sapiens_hsa04710 | 2.30363347 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.15850518 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 10.4440237 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.70396116 |
| 6 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.67929638 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 1.64865317 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 1.63452750 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.61014213 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53292639 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.50585596 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.47753203 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.46999568 |
| 14 | Focal adhesion_Homo sapiens_hsa04510 | 1.35512334 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.32810856 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.30832853 |
| 17 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.29480474 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.28791485 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.27993187 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.26164370 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.25353314 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.24516471 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.23091642 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.21798408 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.20331499 |
| 26 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.18557541 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.17839503 |
| 28 | Morphine addiction_Homo sapiens_hsa05032 | 1.13089929 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08136305 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06551064 |
| 31 | Cell cycle_Homo sapiens_hsa04110 | 1.04107765 |
| 32 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.04072482 |
| 33 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.03367803 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03052537 |
| 35 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.02325579 |
| 36 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.01653847 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.01459929 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00081582 |
| 39 | Purine metabolism_Homo sapiens_hsa00230 | 1.00029303 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 0.99433284 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96455619 |
| 42 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93965626 |
| 43 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.89142823 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87049287 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86292771 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85936309 |
| 47 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82167322 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81852395 |
| 49 | Glioma_Homo sapiens_hsa05214 | 0.81086354 |
| 50 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80521932 |
| 51 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.79643148 |
| 52 | Melanoma_Homo sapiens_hsa05218 | 0.79435123 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77958823 |
| 54 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77603538 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.77135207 |
| 56 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.76755804 |
| 57 | Adherens junction_Homo sapiens_hsa04520 | 0.76188864 |
| 58 | RNA transport_Homo sapiens_hsa03013 | 0.75022697 |
| 59 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74566216 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74540013 |
| 61 | RNA polymerase_Homo sapiens_hsa03020 | 0.74419688 |
| 62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74391685 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74155463 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74024102 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72316176 |
| 66 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71617214 |
| 67 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.71214431 |
| 68 | Taste transduction_Homo sapiens_hsa04742 | 0.70894730 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69787897 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68911202 |
| 71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67841304 |
| 72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67240451 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67148856 |
| 74 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65770251 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65442399 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64760046 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64724606 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64120803 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63754234 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.63592850 |
| 81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63430773 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.62094822 |
| 83 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59396246 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59122167 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57936484 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.57844308 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57814599 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55838803 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55587878 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55418734 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.54606979 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53713358 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53496073 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52867473 |
| 95 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52740104 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52302029 |
| 97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50494901 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50472843 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50413538 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50197401 |
| 101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49309576 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49131610 |
| 103 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48098939 |
| 104 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47525785 |
| 105 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47135629 |
| 106 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.47007590 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.46066384 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44545312 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43807136 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43769516 |
| 111 | Melanogenesis_Homo sapiens_hsa04916 | 0.42661182 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.42600323 |
| 113 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42045904 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41022898 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40824020 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40703714 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40381833 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.40120489 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39905336 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38701440 |
| 121 | Salivary secretion_Homo sapiens_hsa04970 | 0.37859311 |
| 122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37815185 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37613807 |
| 124 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37459401 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36964723 |
| 126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36716244 |
| 127 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36673956 |
| 128 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35649547 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.35538934 |
| 130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.34765732 |
| 131 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34718738 |
| 132 | Long-term depression_Homo sapiens_hsa04730 | 0.33855154 |
| 133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33399995 |
| 134 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33094691 |

